Novocure Stock Technical Analysis
| NVCR Stock | USD 11.39 0.01 0.09% |
As of the 19th of February, Novocure secures the Mean Deviation of 2.92, downside deviation of 4.44, and Risk Adjusted Performance of 0.0252. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novocure, as well as the relationship between them. Please verify Novocure jensen alpha and downside variance to decide if Novocure is priced some-what accurately, providing market reflects its recent price of 11.39 per share. Given that Novocure has jensen alpha of 0.0067, we recommend you to check Novocure's last-minute market performance to make sure the company can sustain itself at a future point.
Novocure Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novocure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NovocureNovocure's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Novocure Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 25.21 | Strong Buy | 7 | Odds |
Most Novocure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Novocure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Novocure, talking to its executives and customers, or listening to Novocure conference calls.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Novocure have expansion opportunities? Factors like these will boost the valuation of Novocure. Anticipated expansion of Novocure directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Novocure demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.06) | Earnings Share (1.61) | Revenue Per Share | Quarterly Revenue Growth 0.078 | Return On Assets |
Understanding Novocure requires distinguishing between market price and book value, where the latter reflects Novocure's accounting equity. The concept of intrinsic value - what Novocure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Novocure's price substantially above or below its fundamental value.
It's important to distinguish between Novocure's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novocure should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Novocure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Novocure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novocure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novocure.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Novocure on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Novocure or generate 0.0% return on investment in Novocure over 90 days. Novocure is related to or competes with Azenta, Kestra Medical, STAAR Surgical, BioLife Solutions, Neogen, Evotec SE, and Teladoc. NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating ... More
Novocure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novocure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novocure upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.44 | |||
| Information Ratio | 0.0078 | |||
| Maximum Drawdown | 31.62 | |||
| Value At Risk | (6.51) | |||
| Potential Upside | 4.95 |
Novocure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novocure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novocure's standard deviation. In reality, there are many statistical measures that can use Novocure historical prices to predict the future Novocure's volatility.| Risk Adjusted Performance | 0.0252 | |||
| Jensen Alpha | 0.0067 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.058 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novocure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novocure February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0252 | |||
| Market Risk Adjusted Performance | 0.068 | |||
| Mean Deviation | 2.92 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 4.44 | |||
| Coefficient Of Variation | 4533.85 | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | 0.0078 | |||
| Jensen Alpha | 0.0067 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.058 | |||
| Maximum Drawdown | 31.62 | |||
| Value At Risk | (6.51) | |||
| Potential Upside | 4.95 | |||
| Downside Variance | 19.74 | |||
| Semi Variance | 17.84 | |||
| Expected Short fall | (3.02) | |||
| Skewness | 0.5385 | |||
| Kurtosis | 5.67 |
Novocure Backtested Returns
Currently, Novocure is somewhat reliable. Novocure has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Novocure, which you can use to evaluate the volatility of the firm. Please verify Novocure's Mean Deviation of 2.92, downside deviation of 4.44, and Risk Adjusted Performance of 0.0252 to check out if the risk estimate we provide is consistent with the expected return of 0.025%. The company secures a Beta (Market Risk) of 1.52, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novocure will likely underperform. Novocure right now secures a risk of 4.64%. Please verify Novocure downside variance, as well as the relationship between the accumulation distribution and price action indicator , to decide if Novocure will be following its current price movements.
Auto-correlation | -0.54 |
Good reverse predictability
Novocure has good reverse predictability. Overlapping area represents the amount of predictability between Novocure time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novocure price movement. The serial correlation of -0.54 indicates that about 54.0% of current Novocure price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 2.07 |
Novocure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Novocure Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novocure volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Novocure Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novocure on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novocure based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novocure price pattern first instead of the macroeconomic environment surrounding Novocure. By analyzing Novocure's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novocure's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novocure specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 55.26 | 61.56 | 70.79 | 72.8 | PTB Ratio | 4.38 | 8.92 | 8.03 | 13.13 |
Novocure February 19, 2026 Technical Indicators
Most technical analysis of Novocure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novocure from various momentum indicators to cycle indicators. When you analyze Novocure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0252 | |||
| Market Risk Adjusted Performance | 0.068 | |||
| Mean Deviation | 2.92 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 4.44 | |||
| Coefficient Of Variation | 4533.85 | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | 0.0078 | |||
| Jensen Alpha | 0.0067 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.058 | |||
| Maximum Drawdown | 31.62 | |||
| Value At Risk | (6.51) | |||
| Potential Upside | 4.95 | |||
| Downside Variance | 19.74 | |||
| Semi Variance | 17.84 | |||
| Expected Short fall | (3.02) | |||
| Skewness | 0.5385 | |||
| Kurtosis | 5.67 |
Novocure February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novocure stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 45,832 | ||
| Daily Balance Of Power | (0.02) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 11.26 | ||
| Day Typical Price | 11.30 | ||
| Price Action Indicator | 0.13 |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.